Skip to contentU
Ultralife Corp
U
ULBIUltralife Corp Q1 2025 · 10-Q
Revenue$50.75M$50.75M+21.0% vs Q1 2024 Net Income$1.87M$1.87M−35.5% vs Q1 2024 EPS Diluted$11.00$11.00+13,650.0% vs Q1 2024 Gross Profit$12,745,000+11.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ultralife Corp · CIK 875657 · Engraved from SEC EDGAR
Operating Cash Flow$3,368,000N/M Free Cash Flowderived$2,473,000N/M Margins · derivedGross margin25.1%−2.2 pt vs Q1 2024
Operating margin6.7%−3.0 pt vs Q1 2024
Net margin3.7%−3.2 pt vs Q1 2024
ended Mar 31, 2025 · filed May 12, 2025 · 42 d after period end